cro.directory
← Home
Chimera Biotec GmbH logo

Chimera Biotec GmbH

Ultra-sensitive GLP/GCP bioanalytical and immunoassay services

Chimera Biotec offers GLP/GCP ultra-sensitive bioanalysis built on its proprietary Imperacer Immuno-PCR platform. Capabilities cover custom immunoassay development, assay transfer, and ADA/immunogenicity and PK/PD assays down to sub-pg/ml levels.

Phases

Services

Modalities

Technical specifications & accreditations

About this organization

Overview

Chimera Biotec provides ultra-sensitive GLP/GCP bioanalytical support for all phases of drug development, as well as non-regulated rapid discovery-phase research.

Services

  • Custom assay development or assay transfer onto a client's preferred platform
  • Development and validation of ultra-sensitive immunoassays
  • Biomarker menu, ADA/immunogenicity, and PK/PD assays

Technologies and expertise

  • Proprietary Immuno-PCR technology, Imperacer®
  • Beyond-ELISA sensitive immunoassays, including Simoa® (Quanterix) and MSD™ ELISA platforms
  • Ultra-sensitivity regardless of sample volume or matrix, with sensitivity in sub-pg/ml concentrations
  • Work conducted under GLP/GCP regulations in a GLP-certified bioanalytical laboratory

The company states that it has specialized for over 20 years in supporting drug development programs with high bioanalytical quality demands, and that it has a long track record in ultra-sensitive ligand binding assays.

Related companies

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/chimera-biotec.md